NGS Clinical Trials

1 recruiting

Frequently Asked Questions

Common questions about NGS clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting
Early Phase 1

Single Arm Romiplostim to Prevent CIT

Ewings SarcomaChemotherapy Induced Thrombocytopenia
Children's Hospital Medical Center, Cincinnati26 enrolled2 locationsNCT07048249
Recruiting
Not Applicable

Medtronic Terminate AF Study

Persistent Atrial FibrillationLongstanding Persistent Atrial Fibrillation
Medtronic Cardiac Surgery160 enrolled15 locationsNCT03546374
Recruiting

Evaluation of Cell Changes in Blood and Tissue in Cancers of the Lung, Esophagus and Lung Lining

Thoracic CancersLung Cancer NOSMalignant Pleural Mesotheliomas NOS+2 more
National Cancer Institute (NCI)1,310 enrolled1 locationNCT00242723
Recruiting

RASopathy Biorepository

RAS MutationNeurofibromatosis 1Noonan Syndrome+11 more
Children's Hospital Medical Center, Cincinnati1,000 enrolled1 locationNCT04395495
Recruiting

Reflectance Confocal Microscopy and Molecular Correlation in Atypical Melanocytic Lesions

Melanoma (Skin Cancer)Next Generation Sequencing (NGS)Melanocytic Nevi
University of Modena and Reggio Emilia200 enrolled1 locationNCT07277920
Recruiting
Not Applicable

Multitarget Pulse Field Ablation Guided by Endocardial and Non-invasive Atrial Driver Mapping (PFA+ADM) Pilot Study. Development of an Ablation Strategy to Improve the Efficacy of Long Standing Atrial Fibrillation Ablation in Patients With High Comorbidity Burden or Heart Failure

Persistent Atrial Fibrillation Longstanding
Fundacion para la Innovacion en Biomedicina (FIBMED)50 enrolled1 locationNCT07118488
Recruiting
Not Applicable

Diagnostic Value of Next-Generation Sequencing Analysis in Biliary Tract Tumours

HepatectomyNGSStenosis of Bile Duct
IRCCS Azienda Ospedaliero-Universitaria di Bologna50 enrolled1 locationNCT06729944
Recruiting

Research on the Heterogeneity of Taiwanese Breast Cancer Patients by Next Generation Sequencing (NGS) Tools

Breast CancerNext Generation Sequencing (NGS)
vghtpe user1,875 enrolled1 locationNCT04626440